NCT06528314: A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- State
- Under way
- Phase
- Phase 3
- People
- 2,150 planned
- Started
- 4 Oct 2024
- Primary completion
- Feb 2030
- Arms
- EFX 50 mg
- Results
- None posted
- 30 Jul 2024: Trial registered
- 4 Oct 2024: Trial started